Status | Study |
Recruiting |
Study Name: Bucillamine Phase 2 Trial in Patients With Cystinuria Condition: Cystinuria Date: 2016-10-19 Interventions: Drug: Bucillamine Thiol donor which results in a cysteine-bucillamine complex for removing excess cystei |
Not yet recruiting |
Study Name: Lipoic Acid Supplement for Cystine Stone Condition: Cystinuria Date: 2016-09-20 Interventions: Dietary Supplement: Alpha lipoic acid |
Recruiting |
Study Name: Prospective Research Rare Kidney Stones (ProRKS) Condition: Hyperoxaluria Cystinuria Dent Date: 2016-05-11 |
Enrolling by invitation |
Study Name: Sulfamethoxazole for the Treatment of Primary PREPL Deficiency Condition: Hypotonia Cystinuria Syndrome Isolated PREPL Deficiency Date: 2015-10-07 Interventions: Drug: Sulfamethoxazole 60 mg sulfamethoxazole per kg bodyweight (maximal of 3g) divided in 2 doses per d |
Not yet recruiting |
Study Name: TCUPS- Tolvaptan Use in Cyctinuria and Urolithiasis: A Pilot Study Condition: Cystinuria Date: 2015-07-21 Interventions: Drug: Tolvaptan |
Recruiting |
Study Name: PREPL in Health and Disease Condition: Hypotonia-Cystinuria Syndrome Muscle Hypotonia Date: 2014-10-01 Interventions: Procedure: Blood draw Blood dr |
Active, not recruiting |
Study Name: Effect of Increasing Doses of Cystine Binding Thiol Drugs on Cystine Capacity in Patients With Cystinuria Condition: Cystinuria Date: 2014-04-24 Interventions: Drug: CBTD 0-3 gm Oral CBTD 0-3 gm dose/day for 7 days, dose escalation |
Recruiting |
Study Name: Health-related Quality of Life in Rare Kidney Stone Condition: Primary Hyperoxaluria Cystinuria Date: 2014-04-23 Interventions: Other: Health-related Quality of Life in Rare Kidney Stone Questionnaire |
Recruiting |
Study Name: Rare Kidney Stone Consortium Biobank Condition: Primary Hyperoxaluria Dent Disease APRT Deficiency Date: 2013-12-30 |
Active, not recruiting |
Study Name: Cystine Capacity Clinical Study (CysCap) Condition: Cystinuria Date: 2013-06-04 |